RadinAndrew.com

These links are intended for entrepreneurs, particularly for entrepreneurs in biotech and techbio.

Qualifying Investors
What Investors Want to See
Investor Lists
Venture Terms
Summaries of Bio-Tech / TechBio / Tech x Bio
Platformability
Platform Analysis
Business & Platform Strategy
Disease Selection
Biotech Valuation Methods
Biotech Tech Stack
Writing Editing
My Profile

Qualifying Investors

A Method for Innovation-Driven Entrepreneurs to Qualify Investors Andrew Radin
6 Questions to Determine If a Potential Investor Is the Right Investor Murray Newlands
Series A Venture Capital Funding: Finding the Right VC for Your Startup Embroker Team

15+ Ways a Venture Capitalist Says “No” Robbie Allen

MIT Startup Exchange’s Sales Training taught by Miro Kazakoff:

What Investors Want to See

My Christmas List Data Room Suzanne Fletcher
Series A Diligence Checklist YCombinator
Book: Secrets of Sand Hill Road: The Art of the Pitch (page 124-139) Scott Kupor

Investor Lists

List of TechBio Investors Cantos VC
Signal: List of Investors across stages and fields NFX

Venture Terms

Book: Venture Deals Brad Feld, Jason Mendelson
Book: Secrets of Sand Hill Road Scott Kupor
Series A Funding: What Is a Term Sheet and Why Is It Important? Embroker Team

Summaries of Bio-Tech / TechBio / Tech x Bio

New Age Bio-Techs Are Redefining Biotechnology Jason Steiner
The Coming Age for Tech x Bio: The ‘Industrial Bio Complex’ Vijay Pande, a16z
What is TechBio? Cantos VC

Platformability

Platform-Partnership Fit: Business Development for Bio Startups Jorge Conde & Jay Rughani, a16z
What is a Bio Platform For? Judy Savitskaya & Jorge Conde, a16z
New Biotech Corporate Structures: Possible Alternatives For Discovery Platforms and Product Financings Bruce Booth, LifeSciVC
Why Bioplatforms Matter, and Can Even Save the World Avak Kahvejian & Noubar Afeyan, Flagship Pioneering
Built to Last: The Exponential Potential of Bioplatforms Andy Oh & Stephen Beresnson, Flagship Pioneering
Machine learning-powered drug discovery: Now and Tomorrow - Part II. Platform, business model, scaling, and emerging trends Lin Ning, Dolby Ventures

Platform Analysis

Biotech platforms are out, products are back in Richard Murphey, Bay Bridge Bio, June 2022
What are the biotech investment themes that will shape the industry? Olivier Leclerc, Michelle Suhendra, and Lydia The, McKinsey & Company, June 2022
Deep-dive into platform biotech companies: phenotypes, business models, destinations... Liang Chang & Kirill Karlin, Biodraft, Nov 2021
[Biopharma] Platform Deals in 2019 - What can we see? Linda Pullan, Pullan's Pieces #159, May 2020

Business & Platform Strategy

Strategy Under Uncertainty Hugh Courtney, Jane Kirkland, and Patrick Viguerie, Harvard Business Review, 1997
What is Business Strategy? Hugh Courtney, World Economic Affairs, Spring 1998
Platform strategy, explained Zach Church, MIT Sloan, June 2017
Three Elements of a Successful Platform Strategy Mark Bonchek and Sangeet Paul Choudary, Harvard Business Review, January 2013

Disease Selection

A few thoughts on choosing which disease to develop a drug for Celine Halioua

Biotech Valuation Methods

How to calculate the value of drugs and biotech companies Richard Murphey, Bay Bridge Bio
Quantifying risk / reward in biotech investing Richard Murphey, Bay Bridge Bio, September 2023
Navigating Transaction Value at the Early Stage – a Process for Internal and External Preclinical Transaction Analyses Susan Thompson, PhD, Stephan Gauldie, PhD, and Yechan Kang, Back Bay Life Science Advisors, January 2019
Make, Buy Or Partner: Strategic Alliances Continue To Fuel Biopharma Growth Oded Ben-Joseph & Nicholas Frame, In Vivo Citeline Commercial, November 2021
Maximizing Royalty Rate Opportunities in Pharma Licensing Steven Muntner, Medtrack, 2013

Biotech Tech Stack

Doing More with Moore: Biotech’s Tech Moment Jorge Conde & Jay Rughani, a16z

Writing Editing

The 7 Levels of Editing Susan Wyche

My Profile

https://www.linkedin.com/in/radinandrew/

© Andrew Radin 2025